Related Experiment Video
Updated: Aug 16, 2026

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
Published on: November 11, 2018
Specific role for p85/p110beta in GTP-binding-protein-mediated activation of Akt
Hiroshi Kubo1, Kaoru Hazeki, Shunsuke Takasuga
1Division of Molecular Medical Science, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima 734-8551, Japan.
Abstract:
We prepared CHO (Chinese hamster ovary) cells expressing both IR (insulin receptor) and A1R (A1 adenosine receptor). Treatment of the cells with insulin or PIA [N6-(2-phenylisopropyl)adenosine], a specific A(1)R agonist increased Akt activity in the cells in a PI3K- (phosphoinositide 3-kinase) dependent manner. Transfection of p110beta into the cells augmented the action of PIA with little effect on insulin. Introduction of a pH1 vector producing shRNA (short hairpin RNA) that targets p110beta abolished PIA-induced Akt activation. By contrast, an shRNA probe targeting p110alpha did not impair the effects of PIA. The effect of PIA in p110alpha-deficient cells was attenuated effectively by both Deltap85 and betaARK-CT (beta-adrenergic receptor kinase-C-terminal peptide). A Deltap85-derived protein possessing point mutations in its two SH2 domains did not impair PIA action. These results suggest that tyrosine-phosphorylated proteins and Gbetagamma (betagamma subunits of GTP-binding protein) are necessary for the specific function of p110beta in intact cells. The p110beta-middle (middle part of p110beta) may play an important role in signal reception from GPCRs (GTP-binding-protein-coupled receptor), because transfection of the middle part impaired PIA sensitivity.
Insights
Insulin receptor (IR) and A1 adenosine receptor (A1R) signaling in Chinese hamster ovary cells reveal that p110beta is crucial for A1R-mediated Akt activation, independent of p110alpha. This highlights p110beta
Area of Science:
- Cellular signaling pathways
- Molecular biology
- Receptor pharmacology
Background:
- Chinese hamster ovary (CHO) cells co-expressing insulin receptor (IR) and A1 adenosine receptor (A1R) were utilized.
- Both insulin and N6-(2-phenylisopropyl)adenosine (PIA), an A1R agonist, activate Akt via phosphoinositide 3-kinase (PI3K) in these cells.
Purpose of the Study:
- To elucidate the specific roles of PI3K isoforms, p110alpha and p110beta, in mediating Akt activation downstream of IR and A1R.
- To investigate the molecular mechanisms underlying A1R-specific signaling.
Main Methods:
- Gene silencing using short hairpin RNA (shRNA) targeting p110alpha and p110beta.
- Overexpression of specific PI3K subunits and mutated proteins.
- Assessment of Akt activity following receptor stimulation.
Main Results:
- Overexpression of p110beta enhanced PIA-induced Akt activation, while p110alpha overexpression had minimal effect on insulin signaling.
- Silencing p110beta abolished PIA-induced Akt activation, whereas silencing p110alpha did not impair PIA's effects.
- PIA-induced signaling in p110alpha-deficient cells was dependent on tyrosine-phosphorylated proteins and Gbetagamma subunits, suggesting a role for p110beta in GPCR signal transduction.
Conclusions:
- p110beta is essential for A1R-mediated Akt activation, functioning distinctly from p110alpha.
- Tyrosine-phosphorylated proteins and Gbetagamma subunits are critical for p110beta's function in intact cells.
- The middle region of p110beta may be involved in receiving signals from G-protein-coupled receptors (GPCRs).
More Related Videos
Related Concept Videos
Activation and Inactivation of G Proteins
PI3K/mTOR/AKT Signaling Pathway
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
GTPases and their Regulation
Large G-proteins, also known...
GTPases and their Regulation
Large G-proteins, also known...
Amplifying Signals via Enzymatic Cascade

